Efficacy and safety of simeprevir and sofosbuvir with and without ribavirin in subjects with recurrent genotype 1 hepatitis C postorthotopic liver transplant: the randomized GALAXY study.

O'Leary JG, Fontana RJ, Brown K, Burton, Jr JR, Firpi-Morell R, Muir A, et al. Efficacy and safety of simeprevir and sofosbuvir with and without ribavirin in subjects with recurrent genotype 1 hepatitis C postorthotopic liver transplant: the randomized GALAXY study. Transplant international : official journal of the European Society for Organ Transplantation. 2017;30(2):196 - 208.

Publication Type:

Journal Article

Authors:

O'Leary, Jacqueline G.; Robert J Fontana; Brown, Kimberly; Burton, James R. Jr; Firpi-Morell, Roberto; Muir, Andrew; O'Brien, Christopher; Rabinovitz, Mordechai; Reddy, Rajender; Ryan, Robert; Shprecher, Adam; Villadiego, Shirley; Prabhakar, Avinash; Brown, Robert S. Jr

Source:

Transplant international : official journal of the European Society for Organ Transplantation, Volume 30, Issue 2, p.196 - 208 (2017)

Keywords:

infection-hepatitis B, C, liver clinical-other

External Third-party Web Link:

https://www.ncbi.nlm.nih.gov/pubmed/27896858

Export Citation:
RIS Format
Top